Coherus Biosciences | Zysk Brutto Na Sprzedaży





Zysk Brutto Na Sprzedaży Zmiana Data
AbbVie USD 10.47B 605M 2025-09
Acadia Pharmaceuticals USD 257.76M 778K 2025-12
Akebia Therapeutics USD 49.21M 13.25M 2025-03
ALKERMES USD 338.34M 72.51M 2025-12
Alnylam Pharmaceuticals USD 829.31M 219.56M 2025-12
Amarin USD 22.21M 28.15M 2025-09
Amgen USD 6.48B 307M 2025-09
Baxter International USD 577M 373M 2025-12
Biogen USD 1.65B 34.6M 2025-12
BioMarin Pharmaceutical USD 713.01M 81.81M 2025-12
Bristol-Myers Squibb USD 8.79B 110M 2025-09
Coherus Biosciences USD 4.95M 15.34M 2025-03
Eli Lilly USD 14.59B 1.48B 2025-09
Fujifilm JPY 347.51B 14.74B 2025-12
Gilead Sciences USD 6.31B 106M 2025-12
Ironwood Pharmaceuticals USD 85.24M 44.1M 2025-06
Merck USD 13.42B 431M 2025-09
Myriad Genetics USD 143.8M 8M 2025-09
Pacira USD 142.25M 11.34M 2025-12
Perrigo USD 362.2M 14.9M 2025-12
Pfizer USD 3.54B 7.61B 2025-09
PTC Therapeutics USD 148.38M 39.31M 2025-12
Regeneron Pharmaceuticals USD 3.3B 67M 2025-12
Sarepta Therapeutics USD 43.55M 204.36M 2025-12
Teva Pharmaceutical Industries USD 2.66B 351M 2025-12
Vertex Pharmaceuticals USD 2.72B 62.4M 2025-12
Xencor USD 21M 22.61M 2025-09
Zoetis USD 1.64B 73M 2025-12


Coherus Biosciences Zysk Brutto Na Sprzedaży - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - Mar 2026.